Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 199

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Schiffer, Charles A. · 2007 · New England Journal of Medicine

Abstract

A 28-year-old woman with recently diagnosed chronic myelogenous leukemia (CML) presents for consideration of appropriate treatment. No siblings are available as candidate donors for stem-cell transplantation. Imatinib, an inhibitor of the BCR-ABL tyrosine kinase present in almost all CML, is recommended. The patient may need to take imatinib indefinitely to maintain suppression of abnormal bone marrow clones.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmct071828

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 199

Metadata

Authors
Schiffer, C. A.
Venue
New England Journal of Medicine
Published
2007-07-19
Volume
357
Issue
3
Pages
258-265
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1976244025
Cited by
199
References
5
FWCI
16.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia. https://app.cochat.ai/papers/10.1056/nejmct071828
The paper
Schiffer, C. A. (2007). BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia. New England Journal of Medicine. https://doi.org/10.1056/nejmct071828

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.